Your HUPLA Resource Center
1st HUPLA PERIODIC EVALUATION WAS SUCCESSFULLY COMPLETED
With the combined efforts of all three partners the 1st financial and scientific report of HUPLA was submitted timely on July 30 2019. Reviews were positive and reports were accepted in November 2019.
BIOMEDCODE PRESENTS HUPLA RESULTS IN THE 39TH EWRR MEETING, 28 FEBRUARY 2019 IN LYON FRANCE.
Biomedcode presented an abstract entitled “Characterization Of Novel Humanized IL-17 Preclinical Platforms or The Efficacy Evaluation Of Anti-Human Il17 Therapeutics” in the 39thEuropean Workshop for Rheumatology Research that took place on February 28 in Lyon France.